Construction method of drug screening system for treating senile valvular heart disease by single traditional Chinese medicine

A technology of traditional Chinese medicine treatment and construction method, which is applied in compound screening, biochemical equipment and methods, chemical instruments and methods, etc., and can solve the problems of lack of scientific experimental evidence

Pending Publication Date: 2021-05-18
HENAN UNIV OF CHINESE MEDICINE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, as mentioned above, the current screening of anti-CAVD traditional Chinese medicine is mainly based on the inference of traditional Chinese medicine theory, lacking objective scientific experimental evidence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction method of drug screening system for treating senile valvular heart disease by single traditional Chinese medicine
  • Construction method of drug screening system for treating senile valvular heart disease by single traditional Chinese medicine
  • Construction method of drug screening system for treating senile valvular heart disease by single traditional Chinese medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0033] (1) Drug preparation: SD rats were used to prepare drug-containing serum containing 10 kinds of target traditional Chinese medicine single-drug granules, and selected anti-CAVD traditional Chinese medicines searched on CNKI, such as Danshen, Astragalus, and Trichosanthes (approved for use by the country), according to Purchasing single Chinese medicine formula granules that meet the national regulations in accordance with the Pharmacopoeia standards, after water dissolving, convert the dosage according to the conversion method of human-rat body surface area, adult Wistar rats (about 200g body weight), give 4pm-5pm every day for 7 consecutive days On the 8th day, blood was collected at the same time, and the drug-containing serum was separated. The drug-containing serum was inactivated in a water bath at 56°C for 30 minutes (filtered with a sterile filter), and stored at -80°C for later use.

[0034] (2) Construction of drug screening cell detection system

[0035] Cons...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a construction method of a drug screening system for treating senile valvular heart disease by using a single traditional Chinese medicine. The construction method specifically comprises the following steps of constructing pmirGLO-RAGE5'-UTR and pmirGLO-mut-RAGE vectors; annealing the target fragment of the gene to synthesize double-stranded DNA, performing thermal denaturation at 95 DEG C for 2 minutes, lowering the temperature by 1 DEG C every 90 seconds to 25 DEG C, standing for 30 minutes, storing at 4 DEG C, and performing cryopreservation at -20 DEG C for later use; carrying out double enzyme digestion on the pmir GLO vector by using Sac I and Xho I enzymes so as to unlink the pmir GLO vector to be linearized; carrying out DNA recovery on a double-enzyme digestion product through agarose gel electrophoresis, and connecting the linear vector with the RAGE5 '-UTR vector; connecting the mutant target fragments by the same method to construct mutant recombinant vector plasmids; transforming the two recombinant vector plasmids and the no-load plasmid into escherichia coli DH5 alpha, picking bacterial colonies, and extracting and identifying the plasmids; and culturing 293T cells, transferring the 293T cells into plasmids containing recombinant pmirGLO-RAGE5'-UTR or pmirGLO-mut-RAGE through LipofectamineTM2000, transfecting for 24 hours, detecting the transfection efficiency, and selecting stably transfected cells, thereby successfully constructing the screening system. The screening system is simple and effective, and target sites can be replaced for popularization and application.

Description

technical field [0001] The invention relates to a construction method of a screening system, in particular to a construction method of a single traditional Chinese medicine drug screening system for treating senile valvular disease. Background technique [0002] Senile valvular disease is a group of degenerative diseases involving multiple valves, especially valve stenosis or insufficiency caused by aortic valve calcification. As my country gradually enters an aging society, the incidence of senile aortic valve calcification (aortic valve calcification) is increasing year by year. The detection rate of valve calcification in people over 50 years old reaches 12.5%, of which aortic valve involvement accounts for 94.4%. At present, calcified aortic valve disease (CAVD) in the elderly can only be treated with surgery or interventional valve replacement. The current replacement valves are divided into two types: biological valves or mechanical valves. Open the chest to replace t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/85C12N5/10C12Q1/02G01N21/64
CPCC12N15/85C07K14/70503G01N33/5044G01N33/5038G01N21/6486G01N2500/10G01N2500/04
Inventor 陈芳司春婴王丽张炅张艺嘉崔小数樊珂
Owner HENAN UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products